TP53 and neoplasm: In a cell assay, HBx was found to be interacting with P53 directly, and leads to the inhibition of P53 transactivation [12], suggesting that HBx can impair the function of tumor suppressors and consequently elevate the hepatocellular carcinoma (HCC) risk.